The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL
Etai Adam(University of Southern California), Yong‐Mi Kim(Children's Hospital of Los Angeles)
Cited by 16
Related Papers
<i>In vitro</i> and <i>in vivo</i> effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA‑4, in B‑cell acute lymphoblastic leukemia
|Experimental and Therapeutic Medicine|2021|10